As specialist project controls consultants with over 20 years’ experience of completing complex projects within the Pharmaceutical and Biotechnology Sectors, we are uniquely qualified to provide independent project assessments.
The aim of these assessments is to improve schedule quality & cost certainty and to identify potential risks & opportunities that may influence successful project delivery.
The assessments can be offered as part of an integrated project control solution or alternatively they can be offered as a separate service.
Firstly we assess schedule quality; utilizing our industry experience together with “Acumen Fuse” software which ensures best practices are being followed and that the Schedule contains critical path integrity.
Secondly we assess the projects exposure to risk and uncertainty by completing a detailed schedule & cost risk assessment.
The risk assessment gathers risk input data which is then used to complete a Monte Carlo probabilistic analysis using “Acumen Risk / Primavera Risk” software, which determines the most likely date and cost for project completion.
Our independent project assessments ultimately provides a more robust, realistic, achievable schedule, a better understanding of potential risk and greater cost certainty.